In-Person Networking Hours
Case Studies
The Concept

The 6th Biologics World Nordics 2023 event will bring together biologic and biosimilar developers and manufacturers, technology providers, CMOs and CROs from the Nordics region and beyond to explore partnership and technical collaboration opportunities, discuss best R&D and biomanufacturing practises, and debate growth strategies as Nordics developed biologics enter critical clinical phase II and III development stages.

This is the only biologics market place in the Nordics area that demonstrates the region's enormous possibilities and provides a full network for Nordic biologic firms wishing to license/partner with large pharma, CROs, and CDMO/CMOs.

Download Brochure
Biologics World Nordics 2023

Clinical Trials of Biologics & Cell & Gene Therapy Products from Nordics Region

The Nordics region is playing a critical role in expanding medical knowledge and opening the path for revolutionary medicines that hold promise for patients globally. Explore the exciting progress of clinical studies on biologics and cell and gene therapy products from the Nordics biopharma.

High-Throughput Cell Line Development & Cell Culture

High-throughput cell line creation and cell culture have considerably sped the discovery and development of novel biologics, improving the efficiency and scalability of biopharmaceutical manufacturing. Know-how on the latest development of cell line development and cell culture technologies have evolved and potentially changed the biologics drug manufacturing process to be more economically feasible.

Cost Optimisation & Advanced Purification Platforms

Cost optimisation strategies coupled with the utilisation of advanced purification platforms have become essential for the biopharmaceutical industry, enabling efficient and economical production of high-quality therapeutics. Immerse into the most focused biologics downstream processing with the ultimate goal of meeting quality and purity requirements of biologics drug products at lower cost.

Commercialising the R&D Priorities in the Nordics Region

Listen from the Nordic region which demonstrated exceptional process in commercialising its R&D objectives, capitalising on its strong innovation ecosystem, supportive regulatory framework, and strategic alliances to translate cutting-edge research into marketable products and solutions.

Opportunities in the Nordics Biologics Sector, Exploring Growth, Innovation, and Collaboration

The Nordic biologics sector is poised to drive transformative advances in medicine, create new market opportunities, and address unmet medical needs on a global scale by leveraging the region's expertise in biologics R&D and manufacturing, cutting-edge research capabilities, and collaborative approach to healthcare innovation.

Emerging Technologies and Applications: New Modalities, Platform & Technologies

Novel emerging technologies such gene editing and RNA-based therapeutics, have enormous potential for improving patient outcomes, driving precision medicine, and altering the healthcare landscape in the future.

Download Brochure
2023 Speakers
Catch The Limited Super Access In Time To Save BIG!

Networking Package for solution Providers

  • Limited availability
  • Secure 2 Delegate Passes and unlock two additional exclusive 1:1 Meetings!

Service & Solutions Providers

Limited Super £1,050
  • BUY2,GET3
  • BUY3,GET5
  • Limited Super valid until the 31st October 2023

Biopharma (Academic & Research Institutes)

Limited Super £2,250
  • BUY2,GET3
  • BUY3,GET5
  • Limited Super valid until the 31st October 2023
Featured Content
#Fireside Chat

[Fireside chat] Unlocking the Potential of Biologics in the Nordics: Clinical Trials, Commercialisation, and Emerging Technologies

Get Firechat Link

Nordics Biopharma Distribution

Download Here!


Download Here!

It was great to attend the session physically, and have some exchange with industry players and exchange ideas. Thanks IMAPAC for great organisation!

KOH WEI JET, EVF Project Process Manufacturing Leader

Great forum for face to face interactions and for exchange of ideas and information.

WuXi Biologics
Chris Lee, Site Head, Singapore Development and Manufacturing

A well organized ambitious meeting. I hope it will continue to develop in the future.

GSK Vaccines
Jean-Francois Dierick, Strategic Analytical Validation and Lifecycle Lead, Analytical Research and Development

This conference was long overdue in Singapore and critical to making sure that CCT understands current challenges facing our Asian based clients. This allows us to quickly provide new or turn-key solutions and products that meet their needs.

Cold Chain Technologies
Regional Commercial Director

BMA 2022 was an excellently organised event and as a sponsor, participating was very valuable in meeting new connections and engaging with existing customers & contacts. I would recommend anyone involved in the regional biologics industry to participate in the event.

Ciaran O'Keeffe, Director, Business Development & Channel Sales

With the many restrictions and the need to hold the event onsite and online, I do think this event is well planned and held. Easy registration. Spacious, simple and professional settings. All the staffs are very friendly and helpful too. Thank you!

West Pharmaceutical Services
Sr. Technical Account Specialist

Bioworkshops appreciate the effort IMAPAC invested to restore a strong In-person participation to this hybrid event, bringing together many of the biologics manufacturing leaders from Asia along and global experts.

Bioworkshops Limited
Nick Kotlarski, President, VP of BioManufacturing